PMS2 and colorectal carcinoma: Lower BRAF mutation frequency in CRC in Asian countries such as Japan, Russia, Israel and China has been reported previously by many, ranging from 3–6% of all cases and about 15.4% of cases with loss of the expression of MLH1/PMS2 [33,41,42,43,44,45,46,47].